David Thomson
Corporate Officer/Principal chez North Carolina Central University
Profil
David Thomson is currently a Professor of Pharmaceutical Sciences at North Carolina Central University and a Vice President at Shire Human Genetic Therapies, Inc. He was previously the Chief Operating Officer at Precision BioSciences, Inc. from 2019 to 2021.
Thomson holds a doctorate degree from Yale University and the University of Toronto, and an undergraduate degree from the University of Strathclyde.
Postes actifs de David Thomson
Sociétés | Poste | Début |
---|---|---|
North Carolina Central University | Corporate Officer/Principal | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Anciens postes connus de David Thomson
Sociétés | Poste | Fin |
---|---|---|
PRECISION BIOSCIENCES, INC. | Chief Operating Officer | 02/07/2021 |
Formation de David Thomson
Yale University | Doctorate Degree |
University of Toronto | Doctorate Degree |
University of Strathclyde | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PRECISION BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |